Form 8-K - Current report:
SEC Accession No. 0001493152-26-018580
Filing Date
2026-04-22
Accepted
2026-04-22 16:54:22
Documents
13
Period of Report
2026-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40693
2 EX-5.1 ex5-1.htm EX-5.1 15179
3 GRAPHIC ex5-1_001.jpg GRAPHIC 5286
  Complete submission text file 0001493152-26-018580.txt   234088

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nrxs-20260421.xsd EX-101.SCH 3014
5 XBRL LABEL FILE nrxs-20260421_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nrxs-20260421_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3314
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 26884496
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)